Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-60 of 93 for

Edit search filters
  1. Phase 2 Study With TTI-622 And TTI-621 In Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)

    Rochester, MN

  2. Coronary CTA for Radiation Therapy Planning in Lymphoma Patients

    Rochester, MN

  3. FT819 In Subjects With B-cell Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. DNA Sequencing-Based Monitoring Of Minimal Residual Disease To Predict Relapse In Aggressive B-cell Non-Hodgkin Lymphomas

    Rochester, MN

  5. Trial Using Keytruda As Initial Therapy In The Treatment Of Advanced Mycosis Fungoides

    Jacksonville, FL

  6. Phase 1 Trial Of ST-001 NanoFenretinide In Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

    Scottsdale/Phoenix, AZ

  7. A Study To Assess The Efficacy, Safety, Pharmacodynamics, And Pharmacokinetics Of Tazemetostat In Combination With Lenalidomide Plus Rituximab Versus Placebo In Combination With Lenalidomide Plus Rituximab In Adult Patients At Least 18 Years Of Age With Relapsed/Refractory Follicular Lymphoma.

    Jacksonville, FL, Rochester, MN

  8. Compare The Efficacy And Safety Of Golcadomide Plus R-CHOP Vs Placebo Plus RCHOP In Participants With Previously Untreated High-risk Large B-cell Lymphoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Study Of APG-3288 In Relapsed/Refractory Blood Cancers

    Jacksonville, FL

  10. Evaluation of Safety and Efficacy of Allo GDA-201 NK Cells in Patients With Relapsed/Refractory B Cell NHL

    Jacksonville, FL

.

Mayo Clinic Footer